Brief clinical and laboratory observationCortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease
References (8)
- et al.
Medical manipulation of the ductus arteriosus
Lancet
(1975) - et al.
Oral prostaglandin E2 in pulmonary atresia
Lancet
(1979) - et al.
Long-term low-dose prostaglandin E1 administration
J Pediatr
(1980) - et al.
Prostaglandin and damage to ductus arteriosus
Lancet
(1977)
Cited by (246)
Caffey disease is associated with distinct arginine to cysteine substitutions in the proα1(I) chain of type I procollagen
2021, Genetics in MedicineCitation Excerpt :Both can induce cortical hyperostosis when upregulated [25, 30, 31]. Long-term PGE administration in children with ductus-dependent cyanotic congenital heart disease is associated with new bone formation [30]. In Ghosal syndrome, the characteristic increased bone density with predominant diaphyseal involvement is believed to be the result of elevated levels of PGE caused by homozygous missense variants in TBXAS1, encoding the enzyme thromboxane synthase, which converts prostaglandins to thromboxane A2 [32].
Prostaglandins and bone metabolism
2019, Principles of Bone BiologyInfantile cortical hyperostosis: Case report
2016, Revista Chilena de PediatriaCaffey disease: New perspectives on old questions
2014, BoneCitation Excerpt :Thus, suggesting inflammation in Caffey disease to be a local matrix-driven process. 3) Upregulation of COX2/PGE axis and transforming growth factor (TGFβ) signaling have been shown to cause cortical hyperostosis in humans [17,33]. Taken together, these observations argue for a pathogenesis driven not necessarily by gross structural or quantitative defects in type I collagen fibrils, but by a subtle alteration in ECM composition that may affect cell signaling as a result of impaired collagen interactions.